European Archives - Page 23 of 1462 - European Medical Journal

Toripalimab JUPITER-02 and -06 data

Updated clinical data from the Phase III JUPITER-02 and JUPITER-06 trials of the anti-PD1 antibody toripalimab in NPC and OSCC, presented…

Transgender Cancer Care Discrimination Linked to Poorer Outcomes

Cancer care discrimination is more common in transgender and non-binary patients and is linked to poorer self-reported health outcomes.

Moderna initiates phase 3 bird flu vaccine trial

A phase 3 study of Moderna’s investigational mRNA-based H5 pandemic influenza vaccine candidate has been initiated.

UK Lifelong Smoking Ban for People Born After 2008 Clears Parliament

The Tobacco and Vapes Bill, banning anyone born after 2008 from ever being legally sold tobacco across the UK, now awaits royal assent.

Very Low Energy Ketogenic Diet Cuts MASLD Liver Fat by 77%

A ketogenic very low energy diet reduced liver fat by 77% in MASLD, outperforming a Mediterranean diet in a small randomised trial.

Left Ventricular Myocardial Strain Shows Sex-Specific Variations on CT

LV myocardial strain reference values from CT show sex-based differences in healthy adults, offering clinicians clearer guidance for interpreting cardiac imaging.

PCI in TAVR Patients Shows Limited Benefit in Frailty

PCI in TAVR patients who were frail was associated with a significantly higher risk of bleeding complications (hazard ratio: 2.51; 95% confidence interval: 1.23–5.11; p=0.011).

US court blocks CDC vaccine advisory panel appointments

A US court issued a preliminary injunction last month to freeze ACIP appointments, raising vaccination concerns for the upcoming respiratory disease season.

Elevated LDH Linked to Poor Outcomes in Advanced Non-Diabetic CKD

Higher LDH levels are linked to increased risk of renal decline and cardiovascular events in patients with advanced non-diabetic CKD.

What Even Is ‘Moderate’ IBD? Experts Can’t Agree

New research reveals a lack of consensus in defining moderate Crohn’s disease and ulcerative colitis, limiting optimal treatment decisions.